Your browser doesn't support javascript.
loading
Medical Treatment Options for Ulcerative Colitis.
Sleiman, Joseph; Bassi, Mehak; Tsipotis, Evangelos; Charabaty, Aline.
Afiliación
  • Sleiman J; Department of Gastroenterology, Hepatology and Nutrition, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
  • Bassi M; Division of Gastroenterology and Hepatology, Saint Peter's University Hospital, Rutgers University, New Brunswick, New Jersey.
  • Tsipotis E; Division of Gastroenterology and Hepatology, Augusta University, Augusta, Georgia.
  • Charabaty A; Division of Gastroenterology and Hepatology, Johns Hopkins University, Baltimore, Maryland.
Clin Colon Rectal Surg ; 35(6): 428-436, 2022 Nov.
Article en En | MEDLINE | ID: mdl-36591395
ABSTRACT
The landscape of management of ulcerative colitis, a type of inflammatory bowel disease, continues to change with advancement in pharmaceutical options as well as clinical treatment targets. Ulcerative colitis primarily involves the superficial layers of the large bowel, and cause active inflammation that can affect the colon from the rectum to the cecum in a relapsing and a remitting course. In this review, we provide evidence-based guidance on the selection of appropriate medical therapies based on individual patient and disease characteristics, with a focus on biologics and small molecules. We also review the role of surgery and management of acute severe ulcerative colitis.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Guideline Idioma: En Revista: Clin Colon Rectal Surg Año: 2022 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Guideline Idioma: En Revista: Clin Colon Rectal Surg Año: 2022 Tipo del documento: Article